144 related articles for article (PubMed ID: 12067901)
1. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
3. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Wu J; Peng L; McMahon GA; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1565-70. PubMed ID: 19574558
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP
J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
[TBL] [Abstract][Full Text] [Related]
8. Do PAI-1 and vitronectin promote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain.
Konstantinides S; Schäfer K; Loskutoff DJ
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1943-5. PubMed ID: 12482815
[No Abstract] [Full Text] [Related]
9. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.
Eitzman DT; Westrick RJ; Nabel EG; Ginsburg D
Blood; 2000 Jan; 95(2):577-80. PubMed ID: 10627465
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
11. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin.
Podor TJ; Peterson CB; Lawrence DA; Stefansson S; Shaughnessy SG; Foulon DM; Butcher M; Weitz JI
J Biol Chem; 2000 Jun; 275(26):19788-94. PubMed ID: 10764803
[TBL] [Abstract][Full Text] [Related]
12. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.
Ploplis VA; Cornelissen I; Sandoval-Cooper MJ; Weeks L; Noria FA; Castellino FJ
Am J Pathol; 2001 Jan; 158(1):107-17. PubMed ID: 11141484
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.
Carmeliet P; Moons L; Lijnen R; Janssens S; Lupu F; Collen D; Gerard RD
Circulation; 1997 Nov; 96(9):3180-91. PubMed ID: 9386191
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin.
Koschnick S; Konstantinides S; Schäfer K; Crain K; Loskutoff DJ
J Thromb Haemost; 2005 Oct; 3(10):2290-5. PubMed ID: 16194205
[TBL] [Abstract][Full Text] [Related]
15. Vitronectin inhibits the thrombotic response to arterial injury in mice.
Fay WP; Parker AC; Ansari MN; Zheng X; Ginsburg D
Blood; 1999 Mar; 93(6):1825-30. PubMed ID: 10068653
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of neointima formation following arterial injury in PAI-1 deficient mice.
Ploplis VA; Castellino FJ
Ann N Y Acad Sci; 2001; 936():466-8. PubMed ID: 11460504
[TBL] [Abstract][Full Text] [Related]
17. Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.
Brandal S; Blake CM; Sullenger BA; Fortenberry YM
Nucleic Acid Ther; 2011 Dec; 21(6):373-81. PubMed ID: 22103403
[TBL] [Abstract][Full Text] [Related]
18. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.
DeYoung MB; Tom C; Dichek DA
Circulation; 2001 Oct; 104(16):1972-1. PubMed ID: 11602503
[TBL] [Abstract][Full Text] [Related]
20. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]